about
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceu...
Read More
10.20
0.22
(2.20%)
538.6K
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Medium Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Rocket
These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials.
View Similar
Embed DVM
Immatics NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..